Immune‐mediated ECM depletion improves tumour perfusion and payload delivery

Abstract High extracellular matrix (ECM) content in solid cancers impairs tumour perfusion and thus access of imaging and therapeutic agents. We have devised a new approach to degrade tumour ECM, which improves uptake of circulating compounds. We target the immune‐modulating cytokine, tumour necrosi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yen Ling Yeow, Venkata Ramana Kotamraju, Xiao Wang, Meenu Chopra, Nasibah Azme, Jiansha Wu, Tobias D Schoep, Derek S Delaney, Kirk Feindel, Ji Li, Kelsey M Kennedy, Wes M Allen, Brendan F Kennedy, Irma Larma, David D Sampson, Lisa M Mahakian, Brett Z Fite, Hua Zhang, Tomas Friman, Aman P Mann, Farah A Aziz, M Priyanthi Kumarasinghe, Mikael Johansson, Hooi C Ee, George Yeoh, Lingjun Mou, Katherine W Ferrara, Hector Billiran, Ruth Ganss, Erkki Ruoslahti, Juliana Hamzah
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Springer Nature 2019-11-01
Edice:	EMBO Molecular Medicine
Témata:	extracellular matrix immune cells peptide solid tumour tumour necrosis factor alpha
On-line přístup:	https://doi.org/10.15252/emmm.201910923
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!